Momentous Ashwagandha (NooGandha NSF Certified for Sport, 300mg)Review 2026

Verdict: BUY (athlete-tier). EDE Score 88/100. Momentous Ashwagandha NooGandha is the only NSF Certified for Sport ashwagandha currently in the mainstream US market: every batch tested for 290 WADA-banned substances, NooGandha proprietary extract with liposomal delivery technology, flexible 1-2 capsule daily dosing covers the full clinical range. The trade-off versus our category alternative (Sports Research Ashwagandha KSM-66, BUY 89) is withanolide concentration: NooGandha at 3.5-4% delivers fewer active compounds per gram than KSM-66 at 5% or Sensoril at 10%. The Ashwagandha category does not yet have a TOP PICK because no current product combines NSF Sport certification with KSM-66 or Sensoril active content. For drug-tested athletes, NCAA athletes, military, and first responders who need NSF Sport on every supplement input, this is the right buy.

This article contains paid links. We may earn a commission if you purchase through these links. Commissions never influence our scoring. Read our methodology and editorial policy.

At a glance

Metric	Value
Brand	Momentous
Product	Ashwagandha (NooGandha NSF Certified for Sport)
Form	Vegetarian capsule (HPMC)
Servings per bottle	60 capsules
Per-capsule dose	300 mg NooGandha extract (3.5-4% withanolides)
Brand-recommended daily dose	1 capsule once or twice daily (300-600 mg)
Clinical effective dose	300-600 mg/day standardized extract
Other ingredients	Rice flour, hypromellose, calcium laurate, silica
Third-party testing	NSF Certified for Sport (every batch)
Price brand-direct	$24.95
CPED at 1 capsule per day	$0.42 per effective day
EDE Score	88/100
Verdict	BUY (athlete-tier)

Why this product matters for men 40+

Ashwagandha (Withania somnifera) is the most clinically validated adaptogen herb in modern supplement use, with over 30 randomized controlled trials documenting effects on cortisol, perceived stress, sleep quality, testosterone, muscle strength, and cognitive performance. For men 40 and older, the use case stack is broad: chronic stress modulation, HPA axis regulation, sleep architecture support, and modest testosterone elevation in subjects with high baseline cortisol or low testosterone status.

The Chandrasekhar 2012 RCT in 64 chronically stressed adults remains one of the most cited trials in the space: 60 days of 600 mg/day of standardized ashwagandha extract reduced perceived stress scale scores by 44%, reduced morning cortisol by 28%, and improved general well-being scores significantly versus placebo.¹ The Lopresti 2019 follow-up trial in 60 adults with high stress replicated the cortisol reduction effect at the same dose.²

For testosterone specifically, the Wankhede 2015 RCT in 57 untrained men supplementing 600 mg/day of standardized ashwagandha alongside an 8-week resistance training program showed a 14.7% increase in serum testosterone versus 2.6% in placebo, alongside greater muscle strength and size gains.³ Subsequent trials have replicated the pattern with effect sizes ranging from 10-20% testosterone increase, most pronounced in men with baseline testosterone in the lower normal range or with high training stress.

The clinical effective dose for adult men, based on the cluster of RCTs, sits at 300-600 mg per day of standardized ashwagandha extract. Lower doses (100-250 mg of high-concentration extracts like Sensoril) can be effective when the withanolide content is elevated. Higher doses (up to 1200 mg) have been studied but show minimal incremental benefit over 600 mg.

This is the dose target Momentous Ashwagandha hits at the brand-recommended 1-2 capsule daily regimen (300-600 mg). The differentiating factor is the choice of extract: NooGandha rather than KSM-66 or Sensoril.

Editorial commentary

Momentous Ashwagandha is the only NSF Certified for Sport ashwagandha product currently in the mainstream US market that we are aware of, per Momentous's own marketing claim corroborated by our category review. This is a meaningful credential for drug-tested athletes, NCAA athletes, military service members, and first responders who require every supplement input to carry NSF Sport certification.

The choice of NooGandha as the active extract is the central editorial fact about this product. NooGandha is a proprietary ashwagandha extract from Specnova (the ingredient supplier), characterized by:

• Combined root and leaf extract (versus root-only for KSM-66, root + leaf for Sensoril)
• Standardization to 3.5-4% withanolides
• Liposomal delivery technology (proprietary lipid encapsulation)

Compared to the two dominant patented ashwagandha extracts in the clinical literature:

• KSM-66 (Ixoreal Biomed): root-only full-spectrum extract, standardized to 5% withanolides minimum, the most clinically studied ashwagandha extract with 30+ published RCTs.
• Sensoril (Natreon): root + leaf concentrated extract, standardized to 10% withanolides plus 32% oligosaccharides, the second most studied with 8+ RCTs typically using lower doses (125-250 mg).
• NooGandha (Specnova): root + leaf extract with liposomal delivery, standardized to 3.5-4% withanolides, newer and with thinner published clinical evidence base.

NooGandha's withanolide concentration is mathematically lower than both KSM-66 and Sensoril. At 600 mg daily NooGandha (4% withanolides), the buyer receives approximately 24 mg of withanolides. The same 600 mg dose of KSM-66 (5% withanolides) delivers 30 mg. A 250 mg dose of Sensoril (10% withanolides) delivers 25 mg. So NooGandha at full clinical dose delivers slightly less active compound than the alternatives.

Momentous's marketing claims NooGandha delivers "higher concentration of compounds than any other ashwagandha extract on the market". This claim does not align with our reading of the data. KSM-66 has higher withanolide concentration. Sensoril has roughly 2.5x higher withanolide concentration. The marketing claim is misleading on the specific metric of withanolide percentage.

The mitigating factor is liposomal delivery. Liposomal encapsulation can increase bioavailability of poorly absorbed compounds by 3-5x in some studies. However, ashwagandha withanolides are not particularly difficult to absorb in the first place, and the published pharmacokinetic comparison between NooGandha and other ashwagandha extracts is limited. We treat the liposomal claim as a partial bioavailability advantage rather than a full compensation for lower withanolide content.

This is why Momentous Ashwagandha scores 88 (BUY athlete-tier) rather than 90+ (TOP PICK). The product carries the gold standard certification (NSF Sport) but the active content tier is below KSM-66 and Sensoril. Per our Pattern 5 framework, TOP PICK requires both certification AND optimal active content. Missing one of the two specs locks the product to BUY tier.

Pattern 4 (athlete-tier coexists with general-tier) is now extended to four categories in our catalog: Tongkat Ali (Nootropics Depot 90 + Momentous 77), Vitamin D (Sports Research 90 + Momentous 88), Magnesium (Klean Athlete 87 + Pure Encapsulations 84), and now Ashwagandha (Sports Research KSM-66 89 + Momentous NooGandha 88).

The Ashwagandha category has a structural editorial gap worth noting explicitly: there is no current product combining NSF Sport certification with KSM-66 or Sensoril active content at clinical dose. A theoretical TOP PICK candidate would require all of: NSF Certified for Sport, KSM-66 or Sensoril extract, 600 mg standardized clinical dose, sub-$0.80 CPED. Such a product does not yet exist commercially. Until it does, Ashwagandha remains a BUY-tier-only category.

What is actually in it

Ingredient	Form	Dose per capsule	Clinical effective dose	% at 1 cap	% at 2 caps	Evidence level
NooGandha (Ashwagandha extract)	Withania somnifera root + leaf, liposomal, 3.5-4% withanolides	300 mg	300-600 mg/day	100% (clinical low)	200% (clinical high)	strong (general ashwagandha); moderate (NooGandha specific)

Other ingredients (inactives): Rice flour (filler), hypromellose (vegetarian capsule shell), calcium laurate (lubricant), silicon dioxide (anti-caking).

This is a single-active formulation with four standard pharmaceutical inactives. The NooGandha extract itself is a proprietary preparation that combines ashwagandha root and leaf with liposomal lipid encapsulation. The withanolide standardization (3.5-4%) is disclosed on the label, which is more transparency than many ashwagandha products provide. KSM-66 and Sensoril both disclose withanolide percentage; generic root powder products typically do not.

Calcium laurate is an unusual lubricant choice (most capsule products use magnesium stearate or stearic acid). Calcium laurate provides similar lubrication function and is generally regarded as safe; the choice may reflect formulation optimization for the liposomal carrier or sourcing preferences.

EDE Score breakdown

Criterion	Weight	Score (0-100)	Weighted contribution
Dose Efficacy	30%	78	23.4
Bioavailability	20%	92	18.4
Third-Party Testing	15%	100	15.0
Label Transparency	15%	100	15.0
Manufacturer Reputation	10%	88	8.8
Community Sentiment	5%	50	2.5
Price Per Effective Dose	5%	100	5.0
Total EDE Score	100%		88/100

See full methodology

Notes on each criterion:

Dose Efficacy (78): Per-capsule (300 mg) matches clinical low. Brand-recommended 2-capsule regimen (600 mg) reaches clinical full. The withanolide concentration (3.5-4%) is structurally lower than KSM-66 (5%) and Sensoril (10%), delivering approximately 20-50% less active compound per gram of extract at equivalent doses. Liposomal delivery partially mitigates but published PK data is limited. Net score reflects clinical-dose regimen but lower active content vs alternatives.

Bioavailability (92): NooGandha proprietary liposomal-delivered extract. Patented form with theoretical bioavailability advantage from lipid encapsulation. Sits between KSM-66 (95) and Sensoril (90) in our methodology rubric, accounting for both the liposomal advantage and the lower withanolide concentration limiting peak active compound absorption.

Third-Party Testing (100): NSF Certified for Sport. Verified on the NSF Sport database. Every batch tested for 290 WADA-banned substances and label accuracy. The only NSF Sport ashwagandha currently in the mainstream US market.

Label Transparency (100): Single active ingredient with exact mg disclosed plus withanolide standardization range disclosed (3.5-4%). All four inactives disclosed.

Manufacturer Reputation (88): Momentous, premium athlete-focused brand, scientific advisory backing (Dr. Andrew Huberman, Dr. Andy Galpin), institutional partnerships (USOPC, multiple NFL teams), no FDA recalls or warning letters since 2020 founding. Same score as our Momentous Vitamin D3 5000 IU NSF Sport review.

Community Sentiment (50): Phase 1 default. Reddit Intelligence layer arrives Q3 2026.

Price Per Effective Dose (100): CPED $0.42 at brand-recommended 1-capsule clinical low regimen. Below $0.50 threshold = max score. At full 2-capsule clinical regimen, CPED rises to $0.83 per effective day (still below $1.00 band).

What we like

• NSF Certified for Sport, every batch tested. The only NSF Sport ashwagandha currently in mainstream US market. Verified on the NSF Sport database. Drug-tested athletes (NCAA, NFL, MLB, NBA, USOPC, World Athletics) can take this with zero supplement-sourced positive risk.
• Liposomal delivery technology in NooGandha extract. Lipid encapsulation theoretically improves bioavailability of withanolides versus standard powder extracts.
• Flexible 1-2 capsule daily dosing covers the full clinical range (300-600 mg). Buyers can titrate based on individual stress profile, training load, and observed response.
• Withanolide standardization disclosed on label (3.5-4%). More transparency than generic root powder products that hide active compound percentage.
• Single-active formulation with four standard pharmaceutical inactives. No proprietary blend, no botanical complex masking.
• Clean manufacturer reputation: Momentous launched 2020 with scientific advisory backing, institutional partnerships, no recalls.
• Vegan, GMO-free, gluten-free. Capsule shell uses vegetarian HPMC.
• Wide retail availability: brand-direct, Amazon, Vitacost, the Feed, Vitamin Shoppe, Recovery for Athletes, multiple specialty retailers.

What we don't like

• NooGandha withanolide concentration (3.5-4%) is structurally lower than KSM-66 (5%) and Sensoril (10%). At the same total extract dose, fewer active compounds are delivered. Marketing claim of "highest concentration of any ashwagandha extract" does not align with published withanolide standardization data for KSM-66 and Sensoril.
• Liposomal bioavailability claim is not strongly supported by published comparative pharmacokinetic studies between NooGandha and the dominant clinical extracts. Treated as a partial advantage, not a full compensation for lower active content.
• Per-capsule dose (300 mg) is below clinical full (600 mg). Buyers wanting full-dose effect must take 2 capsules daily, doubling CPED to $0.83.
• Higher per-bottle price ($24.95 for 60 servings) than non-NSF alternatives. Sports Research Ashwagandha KSM-66 (BUY 89) runs around $20 for 90 capsules at 600 mg KSM-66 each, materially better economics for non-drug-tested buyers.
• 60-capsule bottle at full 2-cap regimen = 30 days of dosing. Shorter day-supply than competitor 90-cap or 120-cap bottles in the category.
• Published clinical evidence base for NooGandha specifically is thinner than for KSM-66 (30+ RCTs) and Sensoril (8+ RCTs). Most ashwagandha clinical claims rely on extrapolation from KSM-66 and Sensoril dose-response data.
• iHerb listing not consistently available for this specific SKU. Brand-direct, Amazon, and specialty retailers only as of publication date.

Cost per effective day (CPED)

Bottle price (brand-direct): $24.95
Servings per bottle: 60 capsules
Per-capsule dose: 300 mg NooGandha extract
Brand-recommended dosing options:
  - 1 capsule daily (300 mg, clinical low): 60 days dosing, CPED $0.42
  - 2 capsules daily (600 mg, clinical full): 30 days dosing, CPED $0.83

Momentous Ashwagandha costs $0.42 per effective day at the brand-recommended 1-capsule clinical low regimen, or $0.83 per effective day at the full 2-capsule clinical regimen.

We use the 1-capsule clinical low ($0.42) as the catalog CPED because it matches the brand's primary dose recommendation and aligns with the lower bound of the published clinical effective range. Buyers seeking full clinical effect should expect to pay double.

For comparison within the ashwagandha category:

Product	Extract type	Per-cap dose	Brand-rec daily	CPED (1 cap)	CPED (2 caps)	EDE Score	Verdict
Sports Research Organic Ashwagandha	KSM-66 (5% withanolides)	600 mg	600-1200 mg	$0.30	$0.60	89	BUY
Momentous Ashwagandha NooGandha NSF Sport	NooGandha (3.5-4% withanolides)	300 mg	300-600 mg	$0.42	$0.83	88	BUY (athlete-tier)

Sports Research Ashwagandha KSM-66 has materially better CPED ($0.30 vs $0.42 at clinical low, $0.60 vs $0.83 at clinical full) AND higher withanolide concentration. Momentous's value-add is exclusively NSF Sport certification. For non-drug-tested buyers, Sports Research is the better mathematical pick.

Ingredient-by-ingredient analysis

NooGandha (Ashwagandha root + leaf extract, 3.5-4% withanolides, liposomal)

Dose in this product: 300 mg NooGandha extract per capsule, 600 mg per 2-capsule clinical full regimen Clinical effective dose: 300-600 mg/day standardized ashwagandha extract Evidence level: Strong for ashwagandha generally, moderate for NooGandha specifically Verdict for this ingredient: Brand-recommended regimen reaches clinical range; active compound content lower per-mg than KSM-66 and Sensoril

Ashwagandha (Withania somnifera) is one of the most extensively studied adaptogen herbs in modern supplement use. The bioactive compounds responsible for its physiological effects are a class of steroidal lactones called withanolides, particularly Withaferin A, Withanolide A, and Withanolide D. The mechanism of action involves modulation of the hypothalamic-pituitary-adrenal (HPA) axis, attenuation of cortisol response to acute and chronic stress, and direct effects on GABAergic neurotransmission and androgen receptor signaling.

For men 40+, the most clinically relevant ashwagandha-related outcomes include:

• Cortisol and perceived stress: Chandrasekhar 2012 showed 60 days of 600 mg/day standardized extract reduced perceived stress scale scores by 44% and morning cortisol by 28% in chronically stressed adults.¹ Lopresti 2019 replicated the cortisol-lowering effect in 60 adults with high stress.²
• Testosterone in resistance-training men: Wankhede 2015 showed 8 weeks of 600 mg/day combined with resistance training increased serum testosterone 14.7% versus 2.6% in placebo, alongside greater muscle strength and hypertrophy gains.³
• Sleep quality: Multiple RCTs have shown improvements in sleep latency, sleep efficiency, and subjective sleep quality at doses of 300-600 mg, particularly in subjects with baseline insomnia or high stress.⁴
• Cognitive performance and memory: Pingali 2014 showed 8 weeks of 500 mg/day improved cognitive task performance and visual memory in healthy adults.⁵
• Muscle strength and recovery: Several RCTs in trained and untrained men show modest gains in strength, recovery, and VO2 max with 500-600 mg/day over 8-12 week training cycles.⁶

The form Momentous uses (NooGandha proprietary extract, 3.5-4% withanolides, liposomal) is an emerging entrant in the ashwagandha extract market. Specnova, the ingredient supplier, has published preliminary pharmacokinetic data suggesting enhanced absorption versus standard powder extracts, though direct head-to-head comparisons with KSM-66 or Sensoril are limited in the public literature. The marketing claim of "highest concentration" refers to total active compound delivery via liposomal enhancement rather than raw withanolide percentage.

In our analysis, NooGandha at 600 mg/day delivers approximately 24 mg of withanolides versus 30 mg from KSM-66 at the same dose. Whether liposomal delivery fully compensates for the 20% lower withanolide content is unsettled. The most defensible interpretation is that NooGandha delivers comparable but not superior active compound exposure versus KSM-66 at equivalent doses.

Take this product in the morning if your primary use case is cortisol regulation and stress modulation during the day. Take it in the evening if your primary use case is sleep support. The "non-sedating" framing in Momentous marketing is accurate at the 300 mg dose; higher doses (600 mg+) can produce mild calming and pro-sleep effects in some users.

Ashwagandha is contraindicated in pregnancy, breastfeeding, hyperthyroidism, autoimmune thyroid disease, and active liver disease. Consult a physician before use if you have any of these conditions.

PubMed: Chandrasekhar K et al. 2012. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root.

Community sentiment summary

Phase 1 default sentiment score: 50/100.

DosedWise will publish aggregated Reddit sentiment for Momentous Ashwagandha across r/Testosterone, r/TRT, r/PeterAttia, r/Supplements, and r/Nootropics in Q3 2026 when our Reddit Intelligence layer ships. Until then, this criterion uses a neutral default and represents 5% of the total EDE Score.

Anecdotal user feedback on the brand's own product page and on third-party retailer pages skews positive on the NSF Sport credential and on the non-sedating framing. The most common third-party critique is the price premium versus non-NSF KSM-66 alternatives. Some users specifically prefer KSM-66 due to the larger clinical evidence base.

[Note: Community sentiment is one signal among seven and is weighted 5% in the EDE Score. See methodology.]

Compared to alternatives

For ashwagandha supplementation, here is how Momentous Ashwagandha compares to alternatives in our catalog and the broader market:

Product	Extract	Per-cap	Withanolides	EDE Score	CPED	Verdict
Sports Research Organic Ashwagandha	KSM-66	600 mg	5%	89/100	$0.30	BUY
Momentous Ashwagandha NooGandha NSF Sport	NooGandha	300 mg	3.5-4%	88/100	$0.42	BUY (athlete-tier)
Thorne Ashwagandha (Shoden)	Shoden (35% withanolides)	120 mg	35%	not yet scored	TBD	TBD
Pure Encapsulations Ashwagandha	Generic 1.5%	500 mg	1.5%	not yet scored	TBD	TBD
Now Foods Ashwagandha	Generic 2.5%	450 mg	2.5%	not yet scored	TBD	TBD

Two products in the ashwagandha category give a clean comparison:

• Sports Research Ashwagandha KSM-66 (BUY 89) is the general-tier pick. KSM-66 has the strongest clinical evidence base of any ashwagandha extract. 600 mg per capsule means single-cap clinical dose. CPED $0.30 is the lowest in the category. No NSF Sport certification.
• Momentous Ashwagandha NooGandha NSF Sport (BUY 88) is the athlete-tier pick. NSF Certified for Sport is the gold standard certification. NooGandha withanolide concentration (3.5-4%) is below KSM-66 (5%) but liposomal delivery may partially compensate. Higher CPED ($0.42).

The score difference between the two is one point (89 vs 88). The CPED difference is significant ($0.30 vs $0.42, approximately 40% premium for Momentous). The NSF Sport premium on this category is roughly aligned with the magnesium category pattern: NSF Sport carries a meaningful cost premium where alternatives without certification offer comparable active content.

The category does not yet have a TOP PICK because no current product combines NSF Sport certification with KSM-66 or Sensoril extract at clinical dose. The structural editorial gap is real and material.

See all ashwagandha reviews

Who should buy this

Momentous Ashwagandha NooGandha NSF Sport is best for:

• Drug-tested athletes (NCAA, NFL, MLB, NBA, USOPC, World Aquatics, World Athletics, NHL) who require NSF Certified for Sport on every supplement input. This is the only NSF Sport ashwagandha currently in mainstream US market.
• Military service members, federal law enforcement, first responders, and pilots subject to random or scheduled drug testing where supplement contamination is a known career risk.
• Stack builders who want every input NSF Sport certified for general quality signaling, not just the highest-risk botanicals.
• Buyers prioritizing the non-sedating positioning of NooGandha for daytime cortisol modulation rather than evening sleep support.
• Functional medicine patients whose practitioners specifically recommend Momentous brand for athletic-tier sourcing.
• Buyers who already use other Momentous products and want consistent brand sourcing across the stack.

Momentous Ashwagandha NooGandha NSF Sport is NOT for:

• Buyers who are not drug-tested. Sports Research Ashwagandha KSM-66 (BUY 89, CPED $0.30) delivers superior withanolide content at lower CPED. The KSM-66 clinical evidence base is also significantly stronger than NooGandha.
• Buyers seeking the highest withanolide concentration available. Thorne Ashwagandha uses Shoden (35% withanolides at 120 mg per capsule), and Sensoril-based products provide 10% withanolides. Both are higher concentration than NooGandha.
• Budget-constrained buyers. Now Foods, Pure Encapsulations, and Nutricost ashwagandha products run at meaningfully lower CPED if NSF Sport certification is not required.
• Buyers seeking ashwagandha primarily for sleep rather than cortisol modulation. The non-sedating positioning of NooGandha may understate the calming benefit some users seek for evening use. KSM-66 or Sensoril at evening dosing may produce more pronounced sleep effects.
• Buyers with hyperthyroidism, autoimmune thyroid disease, active liver disease, pregnancy, or breastfeeding (ashwagandha contraindication regardless of brand or extract).

Stacking notes

• Take in the morning for cortisol modulation and stress resilience effect during the day. NooGandha specifically marketed as non-sedating for daytime use.
• Take in the evening (single 300 mg dose) if your primary use case is sleep latency reduction. Effect is milder than KSM-66 or Sensoril at equivalent doses but still useful.
• Pair with magnesium glycinate for stress and sleep stack. Mg supports HPA axis function and ashwagandha's GABAergic effects.
• Pair with vitamin D3 if baseline 25(OH)D is suboptimal. Both ashwagandha and vitamin D modulate cortisol and testosterone via overlapping mechanisms.
• Take with food for slightly improved absorption (the liposomal carrier interacts with dietary fat).
• Cycling not strictly required. Most clinical trials run 8-12 weeks of continuous supplementation. Some practitioners recommend 2 months on, 1 month off to prevent receptor downregulation, though the published evidence for cycling protocols is limited.
• For testosterone-focused use, combine with adequate sleep (7-9 hours), resistance training (3-5x weekly), and zinc + boron stack. Ashwagandha is potentiating, not replacing, the foundational T-supportive variables.
• Do not combine with sedative medications, immunosuppressants, or thyroid hormone replacement without physician oversight.

Better alternatives

If Momentous Ashwagandha NooGandha NSF Sport does not fit your needs:

1. Sports Research Organic Ashwagandha (EDE 89/100, CPED $0.30): KSM-66 extract at 600 mg per capsule, single-cap clinical dose, lowest CPED in category. Best fit for general buyers prioritizing clinical evidence base and economics.
2. Thorne Ashwagandha (Shoden) (not yet scored): 35% withanolide standardization at 120 mg per capsule. Best fit for buyers wanting maximum withanolide concentration in lowest pill burden. Premium pricing.
3. Sensoril-based ashwagandha (multiple brands) (not yet scored): 10% withanolides, typically dosed 125-250 mg/day. Best fit for buyers responding poorly to KSM-66 or wanting alternative active compound profile.

A future category TOP PICK candidate would require: NSF Certified for Sport, KSM-66 or Sensoril extract, 600 mg standardized clinical dose, sub-$0.80 CPED. We are tracking ingredient supplier announcements for any product that combines these specs.

Frequently asked questions

Is Momentous Ashwagandha NooGandha NSF Sport worth buying?

If you are a drug-tested athlete or value NSF Certified for Sport on every supplement input, yes. EDE 88/100, $0.42 CPED at clinical low (1 capsule daily), NooGandha proprietary liposomal extract. The only NSF Sport ashwagandha currently in mainstream US market. If you are not drug-tested, Sports Research Ashwagandha KSM-66 (BUY 89) gives you stronger clinical evidence base and 30% lower CPED.

What is the difference between NooGandha, KSM-66, and Sensoril?

All three are patented standardized ashwagandha extracts. KSM-66 (Ixoreal Biomed) is root-only at 5% withanolides minimum, with 30+ published RCTs. Sensoril (Natreon) is root + leaf at 10% withanolides plus 32% oligosaccharides, dosed lower (125-250 mg). NooGandha (Specnova) is root + leaf at 3.5-4% withanolides with liposomal delivery technology, newer with thinner clinical evidence base. KSM-66 and Sensoril both have higher withanolide concentration than NooGandha.

Why does Momentous claim NooGandha is the highest concentration ashwagandha?

Momentous's marketing claim refers to total active compound delivery via liposomal absorption enhancement, not raw withanolide percentage. On the specific metric of withanolide standardization, KSM-66 (5%) and Sensoril (10%) are higher concentration than NooGandha (3.5-4%). The "highest concentration" framing is misleading on raw active percentage.

How does Momentous Ashwagandha compare to Sports Research KSM-66?

Sports Research uses KSM-66 (5% withanolides) at 600 mg per capsule with the strongest clinical evidence base in the category. CPED $0.30 per effective day. EDE 89/100. No NSF Sport certification. Momentous uses NooGandha (3.5-4% withanolides) at 300 mg per capsule with NSF Sport certification. CPED $0.42 per effective day. EDE 88/100. For drug-tested athletes Momentous is the right pick. For general buyers Sports Research delivers more withanolides at lower CPED.

Is Momentous Ashwagandha really "non-sedating"?

NooGandha is marketed as non-sedating because its liposomal delivery profile and lower withanolide concentration are claimed to produce focus support without drowsiness. In practice, ashwagandha at 300 mg is mildly calming for most users and not noticeably sedating. At 600 mg some users report mild drowsiness regardless of extract type. Use morning dosing if you want to minimize any calming effect during the day.

Should I take 1 capsule or 2 capsules per day?

Brand recommendation is 1-2 capsules daily based on individual needs. Start with 1 capsule (300 mg, clinical low) for 4-6 weeks to assess response. If subjective stress reduction or other targeted benefit is unclear, increase to 2 capsules (600 mg, clinical full) and reassess at 8-12 weeks. Most published RCTs use 600 mg/day for full clinical effect.

Is this product safe for long-term use?

Ashwagandha is generally well tolerated for long-term use up to 12 months in published trials. Common side effects are mild GI upset (under 5% incidence) and rare drowsiness. Contraindications include pregnancy, breastfeeding, hyperthyroidism, autoimmune thyroid disease, and active liver disease. Periodic thyroid function monitoring is reasonable for users with personal or family history of thyroid issues.

Why is this more expensive than other ashwagandhas?

You are paying for NSF Certified for Sport batch testing (approximately $50,000-100,000 per product per year in maintenance fees passed through), brand reputation premium, and the proprietary NooGandha liposomal delivery technology. Generic KSM-66 ashwagandha (Sports Research, NusaPure) runs $0.20-0.30 per effective day. Generic root-powder ashwagandha runs $0.05-0.15 per effective day. The premium here is paying for the certification and proprietary extract, not the ashwagandha itself.

Where to buy

• Brand-direct (Momentous): $24.95 per 60-serving bottle. Subscription discount available. livemomentous.com
• Amazon: Authorized listing. Amazon listing
• Specialty retailers: Vitacost, the Feed, Recovery for Athletes, Vitamin Shoppe, Scheels, Healf, Fuel Goods, multiple authorized retailers.

We recommend brand-direct or Amazon for the cleanest supply chain. Momentous Ashwagandha SKU availability on iHerb has been inconsistent as of publication date.

Final verdict

BUY (athlete-tier). EDE Score 88/100. CPED $0.42 per effective day at brand-recommended 1-capsule clinical low regimen.

Momentous Ashwagandha NooGandha is the right ashwagandha for drug-tested athletes, military, first responders, and stack builders who want NSF Certified for Sport on every input. The only NSF Sport ashwagandha currently in mainstream US market. NooGandha proprietary liposomal extract, flexible 1-2 capsule clinical-range dosing, transparent withanolide standardization disclosure.

It is not a TOP PICK because the withanolide concentration (3.5-4%) is structurally lower than KSM-66 (5%) and Sensoril (10%), and the published clinical evidence base for NooGandha specifically is thinner than for the dominant patented extracts. The Ashwagandha category currently has no TOP PICK because no product combines NSF Sport certification with KSM-66 or Sensoril active content at clinical dose.

If you decide to buy Momentous Ashwagandha NooGandha NSF Sport:

• Buy brand-direct on livemomentous.com (paid link)
• Buy on Amazon (paid link)

If you would rather try the higher-scoring alternative:

• Sports Research Ashwagandha KSM-66 review (EDE 89, CPED $0.30, KSM-66 5% withanolides, no NSF Sport)

Methodology and disclosures

This review uses the DosedWise Methodology v1.0. The EDE Score formula is:

EDE Score = 
  (Dose Efficacy * 0.30) +
  (Bioavailability * 0.20) +
  (Third-Party Testing * 0.15) +
  (Label Transparency * 0.15) +
  (Manufacturer Reputation * 0.10) +
  (Community Sentiment * 0.05) +
  (Price Per Effective Dose * 0.05)

DosedWise earned no payment from Momentous for this review. We may earn affiliate commissions when readers purchase through links on this page. These commissions never influence scoring. Read our editorial policy.

This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, take prescription medications, or are pregnant or nursing. Ashwagandha is contraindicated in pregnancy, breastfeeding, hyperthyroidism, autoimmune thyroid disease, and active liver disease.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

References

---

Published: 2026-05-04 Last reviewed: 2026-05-04 Author: DosedWise Editorial Team

Footnotes

1. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine. 2012;34(3):255-262. PubMed PMID: 23439798. ↩ ↩²

2. Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186. PubMed PMID: 31517876. ↩ ↩²

3. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition. 2015;12:43. PubMed PMID: 26609282. ↩ ↩²

4. Salve J, Pate S, Debnath K, Langade D. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019;11(12):e6466. PubMed PMID: 32021735. ↩

5. Pingali U, Pilli R, Fatima N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacognosy Research. 2014;6(1):12-18. PubMed PMID: 24497737. ↩

6. Bonilla DA, Moreno Y, Gho C, Petro JL, Odriozola-Martinez A, Kreider RB. Effects of ashwagandha (Withania somnifera) on physical performance: systematic review and Bayesian meta-analysis. Journal of Functional Morphology and Kinesiology. 2021;6(1):20. PubMed PMID: 33670194. ↩